Abstract: The present invention provides devices and methods that treat damaged spinal cord tissue, such as spinal tissue damaged by disease, infection, or trauma, which may lead to the presence of swelling, compression, and compromised blood flow secondary to interstitial edema.
Type:
Grant
Filed:
October 9, 2008
Date of Patent:
September 16, 2014
Assignee:
Wake Forest University
Inventors:
Louis C. Argenta, David L. Carroll, Nicole H. Levi, Jie Liu, Michael J. Morykwas, Stephen Tatter, William D. Wagner
Abstract: Provided herein are methods useful for treating a brain tumor in a subject in need thereof, comprising administering to said subject an active agent comprising poly-FdUMP or a pharmaceutically acceptable salt thereof. Also provided are compositions comprising poly-FdUMP and one or more additional active agents useful for treating a brain tumor.
Abstract: The present invention provides methods and devices for improving cognitive function. In some embodiments, cognitive function is improved by detecting neuronal activity in the CA3 region of a patient's hippocampus and stimulating the CA3 region of the patient's hippocampus responsive to the neuronal activity detected.
Type:
Application
Filed:
March 4, 2014
Publication date:
September 4, 2014
Applicant:
Wake Forest University Health Sciences
Inventors:
Sam Deadwyler, Robert E. Hampson, Mark R. Witcher, Daniel E. Couture, Gautam Popli, Stephen Tatter, Thomas L. Ellis
Abstract: The present invention provides compositions and methods for treating a myopathy. In certain embodiments, the invention provides compositions and methods for treating, improving muscle function, and prolonging survival in a subject with X-linked myotubular myopathy (XLMTM). The present invention provides a method comprising systemic administration of a composition that induces the increased expression of myotubularin in the muscle of a subject. The invention provides sustained regional and global increases in muscle function.
Type:
Application
Filed:
February 28, 2014
Publication date:
September 4, 2014
Applicants:
Wake Forest University Health Sciences, President and Fellows of Harvard College, Genethon
Inventors:
Martin K. Childers, Alan H. Beggs, Anna Maria Buj-Bello
Abstract: The invention provides a method of diagnosing a disease or a predisposition to contract a disease by assaying for mutations of uromodulin (UMOD) within a test subject or patient. The presence of a mutation in the UMOD supports a diagnosis of a disease or a predisposition to contract a disease within the patient.
Type:
Application
Filed:
May 5, 2014
Publication date:
August 28, 2014
Applicants:
University of Pittsburgh - Of the Commonwealth System of Higher Education, Wake Forest University
Inventors:
Thomas C. Hart, Patricia Suzanne Hart, Michael Gorry, Anthony J. Bleyer
Abstract: Provided herein are scaffolds and methods useful to promote the formation of functional clusters on a tissue, for example, motor endplates (MEPs) or a component thereof on skeletal muscle cells or tissue, as well as the use of scaffolds so produced for repairing a tissue injury or defect.
Type:
Application
Filed:
September 28, 2012
Publication date:
August 21, 2014
Applicant:
Wake Forest University Health Sciences
Inventors:
George J. Christ, Justin M. Saul, John B Scott, Benjamin T. Corona, Benjamin S. Harrison, Catherine Ward
Abstract: In one aspect, composite compositions are described herein. In some embodiments, a composite composition comprises an embolic agent and a plurality of nanoparticles dispersed in the embolic agent, wherein a portion of the nanoparticles are individually dispersed in the embolic agent.
Type:
Application
Filed:
September 28, 2012
Publication date:
August 14, 2014
Applicant:
Wake Forest University
Inventors:
Joel L. Berry, David L. Carroll, Pierre H. Rolland
Abstract: Provided herein is an apparatus for printing cells which includes an electrospinning device and an inkjet printing device operatively associated therewith. Methods of making a biodegradable scaffold having cells seeded therein are also provided. Methods of forming microparticles containing one or more cells encapsulated by a substrate are also provided, as are methods of forming an array of said microparticles.
Type:
Application
Filed:
February 20, 2014
Publication date:
July 17, 2014
Applicant:
Wake Forest University Health Sciences
Inventors:
Tao Xu, James J. Yoo, Anthony Atala, Dennis Dice
Abstract: Scintillators of various constructions and methods of making and using the same are provided. In some embodiments, a scintillator comprises at least one radiation absorption region and at least one spatially discrete radiative exciton recombination region.
Abstract: The present invention relates to organic optoelectronic devices and, in particular, to organic photovoltaic devices having a fiber structure. In one embodiment, a photovoltaic device comprises a first electrode comprising an indium tin oxide fiber, at least one photosensitive organic layer surrounding the first electrode and electrically connected to the first electrode, and a second electrode surrounding the organic layer and electrically connected to the organic layer.
Type:
Grant
Filed:
May 1, 2007
Date of Patent:
July 8, 2014
Assignees:
Wake Forest University, Arrowhead Center, Inc.
Inventors:
Seamus A. Curran, David L. Carroll, James Lee Dewald, Sr.
Abstract: The present invention relates generally to a device and method for treating tissues of the central nervous system and more particularly, but not exclusively, to a device and method for treating the brain tissue.
Type:
Grant
Filed:
September 18, 2012
Date of Patent:
July 1, 2014
Assignee:
Wake Forest University Health Sciences
Inventors:
Louis C Argenta, David L Carroll, Nicole H Levi, Michael J Morykwas, Stephen B Tatter, William D Wagner, Jie Liu
Abstract: The invention provides a method of diagnosing a disease or a predisposition to contract a disease by assaying for mutations of uromodulin (UMOD) within a test subject or patient. The presence of a mutation in the UMOD supports a diagnosis of a disease or a predisposition to contract a disease within the patient.
Type:
Grant
Filed:
July 26, 2010
Date of Patent:
June 24, 2014
Assignees:
University of Pittsburgh—Of the Commonwealth System of Higher Education, Wake Forest University
Inventors:
Thomas C. Hart, Patricia Suzanne Hart, Michael Gorry, Anthony J. Bleyer
Abstract: The present invention provides catheters whose lumen may be cleared of obstructions without transducing pressure changes to the patient compartment in which its proximal end is placed. In an illustrative embodiment, the lumen is cleared by a flush fluid supplied from or to a secondary lumen, with the patient compartment isolated with a gate mechanism. In another illustrative embodiment, the lumen is cleared by a progressively expanding balloon therein.
Abstract: A tissue treatment apparatus and method are provided for treating tissue by the application of the time-varying sub-atmospheric pressure. The apparatus includes a cover adapted to cover a wound and adapted to maintain sub-atmospheric pressure the site of the wound. The apparatus further includes a source of suction configured to generate a time-varying sub-atmospheric pressure having a periodic waveform comprising a gradual change in pressure. The suction source cooperates with the cover to supply the time-varying sub-atmospheric pressure under the cover to the wound. The time-varying sub-atmospheric pressure may vary between a first pressure value below the inherent tissue tension of the wound tissue and a second pressure value above the inherent tissue tension of the wound tissue.
Type:
Application
Filed:
November 18, 2013
Publication date:
June 5, 2014
Applicant:
Wake Forest University Health Sciences
Inventors:
Louis C. Argenta, Michael J. Morykwas, Lawrence X. Webb
Abstract: The subject matter relates to relates to a one-bead-one-sequence composition, a library of tagged chemicals comprising a plurality of one-bead-one-sequence compositions, a method for identifying a candidate molecule from a library of tagged chemicals, and a composition produced by a process, all as described herein.
Abstract: A conjugate comprises: (a) a mitochondrial membrane-permeant peptide; (b) an active agent or compound of interest such as a detectable group or mitochondrial protein or peptide; and (c) a mitochondrial targeting sequence linking said mitochondrial membrane-permeant peptide and said active mitochondrial protein or peptide. The targeting sequence is one which is cleaved within the mitochondrial matrix, and not cleaved within the cellular cytoplasm, of a target cell into which said compound is delivered. Methods of use of such compounds are also described.
Abstract: Systems, devices and methods for performing small incision DLEK include providing a corneal transplantation donor tissue graft; then forming the tissue graft into an implantable configuration using the flexible substrate. Related medical kits and tools for forming a compact or rolled donor tissue graft are also described.
Abstract: The invention pertains to methods of producing artificial composite tissue constructs that permit coordinated motion. Biocompatable structural matrices having sufficient rigidity to provide structural support for cartilage-forming cells and bone-forming cells are used. Biocompatable flexible matrices seeded with muscle cells are joined to the structural matrices to produce artificial composite tissue constructs that are capable of coordinated motion.
Type:
Grant
Filed:
March 10, 2006
Date of Patent:
May 20, 2014
Assignee:
Wake Forest University Health Science
Inventors:
Anthony Atala, James Yoo, Grace Lim, Sang Jin Lee
Abstract: A computer-based method for determining a prediction of risk and/or an indication of extent of coronary stenosis in a human subject, comprises the steps of: (a) inputting the level of at least one cholesteryl ester measured in a blood sample collected from said subject; and then (b) inputting the age and gender of said subject; and then (c) generating in said computer from said cholesteryl ester level input, said age input and said gender input a prediction of risk and/or an indication of extent of coronary stenosis blood sample by mass spectrometry.
Type:
Application
Filed:
May 30, 2012
Publication date:
May 15, 2014
Applicant:
Wake Forest University Health Sciences
Inventors:
Lawrence L. Rudel, Chadwick D. Miller, Michael J. Thomas
Abstract: A composition comprising microcapsules, the microcapsules containing both live mammalian ovarian granulosa cells and live mammalian ovarian theca cells, is described. In some embodiments, the granulosa cells and the theca cells are contained in separate microcapsules in the composition; in some embodiments, the granulosa cells and the theca cells are contained together in the same microcapsules in the composition The composition is can be used for estrogen, and optionally also progesterone, delivery, and hence is preferably free or essentially free of oocytes. Methods of using the same and pharmaceutical formulations containing the same are also described.
Type:
Application
Filed:
February 21, 2012
Publication date:
May 8, 2014
Applicant:
Wake Forest University Health Sciences
Inventors:
Emmanuel Opara, James J. Yoo, Justin M. Saul, Sittadjody Sivanandane, Anthony Atala